"Glucuronates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of GLUCURONIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the 6-carboxy glucose structure.
Descriptor ID |
D005965
|
MeSH Number(s) |
D02.241.081.844.915.162 D02.241.152.811.162 D02.241.511.902.915.162 D09.811.922.162
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glucuronates".
Below are MeSH descriptors whose meaning is more specific than "Glucuronates".
This graph shows the total number of publications written about "Glucuronates" by people in this website by year, and whether "Glucuronates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucuronates" by people in Profiles.
-
Age-and Region-Dependent Disposition of Raloxifene in Rats. Pharm Res. 2021 Aug; 38(8):1357-1367.
-
High concentrations of urinary ethanol metabolites in neonatal intensive care unit infants. Pediatr Res. 2020 12; 88(6):865-870.
-
Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in mice. Life Sci. 2015 Oct 15; 139:132-8.
-
Polycyclic aromatic hydrocarbons: determinants of urinary 1-hydroxypyrene glucuronide concentration and risk of colorectal cancer in the Shanghai Women's Health Study. BMC Cancer. 2013 Jun 11; 13:282.
-
Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group. Cancer Chemother Pharmacol. 2008 Nov; 62(6):1027-37.
-
Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracil. Clin Cancer Res. 2007 Feb 01; 13(3):965-71.
-
Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the rhesus monkey. Invest New Drugs. 1993 Nov; 11(4):255-61.
-
Interaction of ethanol oxidation with glucuronidation in isolated hepatocytes. Biochem Pharmacol. 1978; 27(22):2583-8.
-
Aldose reductases from mammalian tissues. Methods Enzymol. 1975; 41:159-65.
-
Purification and immunologic identification of aldose reductases. Diabetes. 1974 May; 23(5):460-8.